The methanol extract of whole Bacopa monniera plants inhibited pancreatic lipase activity in vitro. From this extract we have reported the isolation of 11 triterpene glycosides and 5 phenylethanoid-and/or phenylpropanoid-glycosides. In this paper, we describe the effects of the methanol extract and/or its constituents on pancreatic lipase activity and the isolation of an active constituent, desrhamnosyl isoacteoside. In addition, the structural requirements for its inhibitory effects were examined. We also examined the effects on the elevation of plasma triglyceride (TG) levels in olive oil loaded mice. The major active constituents, desrhamnosyl isoacteoside and plantainoside B, reduced plasma TG levels in the mice. The inhibitory effects of B. monniera and its constituents on pancreatic lipase activity and plasma TG level are reported for the first time.
The Scrophulariaceae plant Bacopa monniera Wettst. is a perennial herb that is widely cultivated in many countries, including China, India, and Japan. In Ayurvedic medicine, B. monniera is widely used as a nerve tonic and a memory enhancer. Past studies have indicated that the alcoholic extract has potential use for the treatment of Alzheimer's disease (AD) [1] [2] [3] [4] . In our previous study, we isolated constituents from the whole plant of B. monniera and examined their inhibitory effects on Aβ42 aggregation [5] as part of our ongoing effort to uncover useful agents for AD [6, 7] .
To identify new functions of this plant, we examined its inhibitory effects on several enzymes, including pancreatic lipase. In this paper, we describe the inhibitory effects of the methanol (MeOH) extract and its active constituents on pancreatic lipase activity and plasma triglyceride levels in olive oil loaded mice.
Pancreatic lipase is one of the therapeutic targets for the treatment of obesity because it is the most important enzyme for lipid absorption [8] . Pancreatic lipase plays a role in the digestion of total dietary lipids (50%-70%) by producing monoglycerides and fatty acids. The inhibition of pancreatic lipase activity would block the breakdown of triglycerides and reduce fat absorption. The inhibition of pancreatic lipase activity has been studied intensively for the development of anti-obesity drugs. Orlistat is a well-known pancreatic lipase inhibitor. However, even though it is one of the most widely used drugs for the treatment of obesity, severe side effects, including gastrointestinal disturbance and oily stools, were reported after prolonged use [9] . Therefore, there is a need to develop a much safer drug from natural products with minimal side effects.
The MeOH extract of B. monniera inhibited pancreatic lipase activity (IC 50 = 316.4 μg/mL). The EtOAc-and 1-BuOH-soluble fractions showed stronger inhibitory effect than its extract, their IC 50 values being 47.5 and 185.8 μg/mL, respectively. The results indicated that the active constituents were present in the EtOAcand 1-BuOH-soluble fractions. Therefore, we initiated an examination for the identification of the active constituents from among the compounds that we have isolated and reported previously [5] . This time around, we additionally isolated desrhamnosyl isoacteoside (1).
Among the constituents, desrhamnosyl acteoside (1) and plantainoside B (2) inhibited pancreatic lipase activity, and their IC 50 values were 33.0 and 32.5 μM, respectively ( Table 2 ). Monnieraside III (3) showed a weak inhibitory effect (inhibition at 100 μM = 21.4%). The other constituents, apigenin (4), a major flavonoid, cucurbitacin E (5), which is known for its cytotoxic activity [10] , and its glucoside, cucurbitacin E-2-O-β-Dglucopyranoside (6), did not show the activity.
Because active constituents 1, 2, and 3 contain caffeic acid in their chemical structures, we tried to examine several related phenylpropanoids and other compounds to clarify the structural 0.0 ± 0.9 -9.2 ± 1.6
Significantly different from the control group, *p<0.05, **p<0.01 requirements for the inhibitory effects. A previous report [11] has described that p-coumaric acid and ferulic acid have weaker effects than caffeic acid. However, as far as we know, there are no detailed reports of the structure-activity relationships of phenylpropanoids that exhibit inhibitory effects on pancreatic lipase activity. Table 3 , caffeic acid (9) and 3,4-dihydroxycinnamic acid (15) possessed the strongest inhibitory effect. The double bond between the 2-and 3-positions seemed to be unrelated to the inhibitory effect, because those two compounds exhibited almost the same effect. A comparison of caffeic acid (9), p-coumaric acid (8) , and cinnamic acid (7) suggested the importance of the catechol group. The same tendency was observed between methyl caffeate (11) and methyl cinnamate (12) and/or between ethyl caffeate (13) and ethyl cinnamate (14) . In addition, the hydroxyl group at the 1-position seemed to be important for the inhibitory effect, based on a comparison between caffeic acid (9) and (E)-3,4dihydroxybenzylideneacetone (10) .
As shown in
Therefore, we examined the effects of major active constituents 1 and 2 on plasma TG levels in olive oil loaded mice. The results are summarized in Table 4 . Compounds 1 and 2 inhibited plasma TG elevation at 2.0 , 4.0 , and 6.0 h.
In conclusion, we isolated desrhamnosyl isoacteoside (1) and confirmed that it is the major active constituent, together with plantainoside (2) . The importance of the catechol group and the hydroxyl group at the 1-position was suggested. In addition, 1 and 2 showed inhibitory effects on plasma TG levels in olive oil loaded mice. These findings suggest that B. monniera whole plant and its active constituents could help prevent obesity.
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Effect on porcine pancreatic lipase activity:
The experiments were performed as described in our previous reports, with slight modification [13, 14] . A suspension of triolein (80 mg), phosphatidylcholine (10 mg), and sodium taurocholate (5 mg) in 9 mL of 0.1 M Tris-HCl buffer (pH 7.0) containing 0.1 M NaCl was homogeneously emulsified in a homogenizer (straight Teflon pestle with a straight glass tube, volume 20 mL). The substrate suspension (0.1 mL) was poured into a test tube and preincubated with 5 μL of test sample in DMSO and 95 μL of Tris-HCl buffer for 3 min at 37°C. An aliquot of either porcine pancreatic lipase (250 mg/mL, type II, Sigma Chemical Co.) (50 μL) or Tris-HCl buffer (50 μL) as blank was added to start the reaction. After incubation for 30 min, the test tube was immediately immersed in boiling water for 2 min to stop the reaction, and then cooled with water. Free fatty acid concentration was determined with a commercial kit (NEFA C-test Wako, Wako Pure Chemical Co., Ltd.). Measurements were performed in quadruplicate, and IC 50 values were determined graphically. The pancreatic lipase inhibitor orlistat was used as reference compound.
The IC 50 value of orlistat, the positive control, was 0.01 μM. All values are expressed as means ± S.E.M. One-way analysis of variance followed by Dunnett's test was used for statistical analysis.
Animals: Male ddY mice were purchased from Japan SLC, Inc. (Shizuoka, Japan). The animals were housed at a constant temperature of 24±1°C and fed standard laboratory chow (MF, Oriental Yeast Co., Ltd., Tokyo, Japan).
The animals were fasted for 20-24 h prior to the experiments, but were allowed free access to tap water. All experiments were performed using conscious mice unless otherwise noted. The experimental protocol was approved by the Experimental Animal Research Committee of Kyoto Pharmaceutical University.
Effect on plasma TG levels in olive oil loaded mice:
The experiments were performed as described in our previous report, with slight modification [15] . Each test sample was administered orally to fasted mice (body weight 30-35 g), and olive oil (10 mL/kg, p.o.) was administered 30 min thereafter. Blood samples (ca. 0.25 mL) were collected from the infraorbital venous plexus under ether anesthesia 2, 4, and 6 h after the oral administration of olive oil. The collected blood samples were immediately mixed with heparin sodium (5 units/tube). After centrifugation of the blood samples, plasma TG was determined enzymatically using the Triglyceride E test Wako (Wako Pure Chemical Co., Ltd.) according to the manufacturer's protocol. The pancreatic lipase inhibitor orlistat was used as reference compound.
